Inhibition of protein synthesis by trichodermol, diacetoxyscirpenol and verrucarin A in cells and spheroplasts of Saccharomyces cerevisiae was investigated. Inhibition was reversible for trichodermol and diacetoxyscirpenol, both drugs being removed from their target site(s) by washing, but was irreversible for verrucarin A. These results are interpreted in relation to variations in chemical structure between these trichothecenes.
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The 12,13-epoxytrichothecenes ( Cells from both strains were, however, similarly inhibited by trichodermol and diacetoxyscirpenol (results not shown).
Protein Synthesis in Yeast Spheroplasts
The above inhibitory studies were then repeated using spheroplasts ( Fig. 3 ) and the data obtained were essentially similar to those shown in Fig. 2 . In general, however, spheroplasts were more sensitive to inhibition than were cells, particularly for diacetoxyscirpenol with 120 jig/ml inhibiting protein synthesis by 85 %. The differences shown previously between the two yeast strains for verrucarin A inhibition ( Fig. 2c & d) were also abolished using spheroplasts. Thus spheroplasts from both strains were (Figs. 4 & 5) . Finally, cells and spheroplasts of A224A were inhibited with verrucarin A, washed free from excess drug and phenylalanine incorporation followed over 24 hours (Fig. 6) . Control cells incorporate all added phenylalanine after approximately 6 hours. Cells previously treated with verrucarin A remain inhibited relative to controls for approximately 6 hours but then commence phenylalanine uptake with a high incorporation level reached by 23-hour incubation. In contrast, spheroplasts remained highly inhibited relative to controls over the total incubation period. Recovery of cells from verrucarin A inhibition does not result from the presence in inhibited cultures of a small proportion of cells resistant to the drug since addition of verrucarin A to recovering cells restores inhibition (Fig. 6a) . Drug release from its receptor site(s) also seems unlikely since spheroplasts remain strongly inhibited over the long incubation period. Possibly initial cultures were less than 100 % inhibited and with removal of excess verrucarin A any few viable cells could multiply.
There is, in fact, a very noticeable increase in the optical density of `inhibited' cultures between 10 and 23 hours incubation (M. CANNON, unpublished observations) but not in spheroplasts where cell division does not take place. Nevertheless spheroplasts, although remaining highly inhibited relative to controls, do incorporate a very small amount of radioactivity linearly over 20 hours incubation, taken to represent background incorporation by a very small proportion of unaffected spheroplasts. A similar very small, but steady incorporation is seen with `inhibited' cells between 0 and 11 hours incubation. In HeLa cells, verrucarin A rapidly induced total "run off" of polyribosomes and inhibited leucine incorporation into protein7). A further Group IV Compound, T-2 toxin, induced only slow "run off" in yeast spheroplasts, an effect presumably related to cell membrane permeability, although in reticulocyte cell-free systems, protein synthesis can be inhibited by approximately 60 % using T-2 toxin at concentrations as low as 0.2 ug/ml2).
Inhibition of cell-free protein synthesis was also studied2) using diacetoxyscirpenol (Group III). This compound was a more effective inhibitor than T-2 toxin, particularly at high drug concentrations.
Group IV compounds inhibit recently-initiated ribosomes very strongly but do not prevent elongation of nascent polypeptide chains that have reached a certain minimal chain length. A residual amount of protein synthesis can thus take place before inhibition becomes complete. Diacetoxyscirpenol also inhibits recently-initiated ribosomes but can, at high concentrations, efficiently block elongation. Our results for diacetoxyscirpenol (Figs. 2 & 3) are thus surprising since a more pronounced inhibitory effect is to be expected. Less is known about the potency of trichodermol as an inhibitor of protein synthesis in vitro. However, other Group I compounds produce, at high drug concentrations, instantaneous and essentially complete inhibition of elongation. Since trichodermol inhibits the peptidyl transferase center on ribosomes and chemically is closely related to trichodermin (Group I) its potency should resemble that of diacetoxyscirpenol2) a prediction supported by our in vivo data ( Fig. 3a & b) .
Trichodermol, diacetoxyscirpenol and verrucarin A are particularly effective inhibitors of protein synthesis in yeast spheroplasts with diacetoxyscirpenol marginally the least and verrucarin A certainly the most potent of these three drugs. Inhibition by trichodermol and diacetoxyscirpenol is readily reversed whereas that by verrucarin A is irreversible. Similar experiments were carried out with HeLa cells and rabbit reticulocyte lysates8) using diacetoxyscirpenol, trichodermin and T-2 toxin. Protein synthesis in HeLa cells was strongly and irreversibly inhibited by both T-2 toxin and diacetoxyscirpenol whereas inhibition by trichodermin was weak and reversible. These results8) for diacetoxyscirpenol are clearly at variance with ours and others9) have claimed that inhibition by diacetoxyscirpenol in vivo in both reticulocytes and tumour cells can be markedly reversed by washing. Other data from L1AO et al.8) also contradict those reported by other groups and claim that T-2 toxin at high concentration inhibits elongation. Others2,7,10) have excluded this possibility.
The published literature concerning trichothecenes is typified by similar contradictions since inhibition can vary depending upon the type and source of experimental system employed and whether in vivo or in vitro conditions are selected. Thus diacetoxyscirpenol is claimed to be at least 20 times more active in whole cells than in cell-free systems whereas other trichothecenes (including fusarenon-X) show no detectable difference in potency9). Furthermore, T-2 toxin can strongly inhibit several systems in vivo with a potency similar to that of diacetoxyscirpenol although verrucarin A is shown relatively to be a poor inhibitor9). The variability observed may in part result from certain trichothecenes exerting in vivo some influence on cell membranes and affecting uptake of certain precursors9). Selected trichothecenes may have a particularly high affinity for biomembrane structures.
Trichodermol and diacetoxyscirpenol are chemically very similar ( Fig. 1) but there are structural differences at R1, R2 and R3. Although esterification of a R2 hydroxyl group, as in trichodermol to trichodermin, increases inhibitory activity this may only happen when R1=H (as in trichodermol being less active than trichodermin). For diacetoxyscirpenol, however, where R1=OH the critical group maybe R32). Thus diacetoxyscirpenol with R3=O-CO-CH3 has Group III activity whereas in the Group I compound trichodermol R3=H. The presence of R3=O-CO-CH3 in diacetoxyscirpenol allows total "run off" at low drug concentrations since this trichothecene binds very weakly to ribosomes carrying nascent polypeptide chains. At high drug concentrations, however, diacetoxyscirpenol binds to ribosomes more efficiently and partially stabilizes polyribosomes. Such chemical differences apparently critically control drug activity in vitro but structural considerations are more difficult to apply to inhibition in vivo. Indeed, although LIAO et al.8) have implied that R3-=O-CO-CH3 in diacetoxyscirpenol causes irreversible inhibition of protein chain initiation our data contradict this hypothesis. Nevertheless, verrucarin A (cf. T-2 toxin) irreversibly inhibits protein syn-NO. 
